Biomedical Engineering Reference
In-Depth Information
Table 19.4 Protection Provided by Fullerenes 1-4 Against General CNS Apoptosis Induced
by 6-OHDA
Maximum protection
against CNS apoptosis
Maximum protection against
dopaminergic CNS apoptosis
Compound
1
23%
ND
2
47%
100%
3
ND
60%
4
42%
60%
Table 19.5 Protection Provided by 4 Against Dopaminergic CNS Apoptosis Induced
by 6-OHDA
Treatment
Animal 1
Animal 2
Animal 3
Animal 4
Animal 5
Control
28
29
30
26
32
6-OHDA
7
8
10
1
3
6-OHDAþ250 mM 4
22
14
21
18
26
Figure 19.7 Protection of CNS dopaminergic neurons from6-OHDA-induced apoptosis by 4. Untreated
(top panels), 6-OHDA plus vehicle treatment (middle panels), and 6-OHDA plus 250 mM 4 (lower panels)
embryos were stained with anti-tyrosine hydroxylase antibody. Five images of each group were examined;
the number of TH-immunoreactive cells clustered in diencephalons (between the eyes) was examined.
In untreated animals, 20-40 TH cells were observed (dark gray arrows). After 6-OHDA treatment, decrease
in the number of TH-immunoreactive cells was observed (1-17) (light gray arrows). After 250 mM
4 treatment, three of the five 4-treated animals showed a normal number of TH-immunoreactive cells with
normal morphology (black arrows).
Search WWH ::




Custom Search